Effect of CYP2C19 gene polymorphism on efficacy of thalidomide-based regimens for the treatment of multiple myeloma

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Volumn 28, Issue 10, 2007, Pages 651-654

  Li, Yong Hua ^a   Hou, Jian ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYP2C19 PROTEIN, HUMAN; THALIDOMIDE; UNSPECIFIC MONOOXYGENASE;

ADULT; AGED; ARTICLE; FEMALE; GENETICS; HUMAN; MALE; MIDDLE AGED; MULTIPLE MYELOMA; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ARYL HYDROCARBON HYDROXYLASES; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; THALIDOMIDE; TREATMENT OUTCOME;

EID: 70450028529     PISSN: 02532727     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)